![](https://investorshub.advfn.com/uicon/38233.png?cb=1590109792)
Friday, February 10, 2006 12:15:55 AM
Key phrase here ... "expedite approval" ... this is where the bigger pharm companies will want to get involved with DNAPrint.
Also of interest .. looking forward to hearing results from the Moffit trials.
"We've been collecting samples all along, but we
just now are in the process of enrolling an additional 100 patients into
a trial at the Moffitt Center, and over the next six to nine months
we'll be finalizing the data."
http://www.twst.com/ceos/ABN618.htm
Their nine months are up. And I think we can all expect the results to be positive when they do come out.
People who say it cannot be done should not interrupt the person doing it.
http://www.perry-mansfield.org/index_fl.html
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM